Efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery disease

American Heart Journal

Volumn 153, Issue 4, 2007, Pages 629-635

  Fox, Kim M ^a   Bertrand, Michel E ^b   Remme, Willem J ^c   Ferrari, Roberto ^d   Simoons, Maarten L ^e   Deckers, Jaap W ^e  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b Cardiology Hospital   (France)

^c Sticares Cardiovascular Research Foundation   (Netherlands)

^d S ANNA HOSPITAL   (Italy)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PERINDOPRIL; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEMOGRAPHY; DRUG EFFICACY; FEMALE; HEART ARREST; HEART DEATH; HEART INFARCTION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVASCULARIZATION; RISK REDUCTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY ARTERIOSCLEROSIS; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PERINDOPRIL; RISK FACTORS;

EID: 33947495798     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.01.032     Document Type: Article

References (23)

1. Okrainec K., Platt R., Pilote L., et al. Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials. J Am Coll Cardiol 45 (2005) 177-184
2. Mukherjee D. Optimizing management of patients with coronary artery disease: how do we get there?. Eur Heart J 26 (2005) 1147-1148
3. Smith Jr. S.C., Dove J.T., Jacobs A.K., et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines. Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 37 (2001) 2215-2239
4. ACC/AHA Writing Committee. Coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Accessed 6 October 2005. Available at:http://www.acc.org/clinical/guidelines/cabg/index_pkt.pdf
5. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302
6. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 327 (1992) 669-677
7. Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342 (1993) 821-828
8. Kober L., Torp-Pedersen C., Carlsen J.E., et al. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. TRAndolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 333 (1995) 1670-1676
9. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355 (2000) 253-259
10. Bertrand M.E., Remme W.J., Fox K.M., et al. Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function-the EUROPA study. Eur Heart J 26 Suppl 1 (2005) 403-617
11. Oosterga M., Voors A.A., Pinto Y.M., et al. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUInapril On Vascular Ace and Determinants of ISchemia. Am J Cardiol 87 (2001) 542-546
12. Kjoller-Hansen L., Steffensen R., and Grande P. The Angiotensin-converting enzyme inhibition Post REvascularization Study (APRES). J Am Coll Cardiol 35 (2000) 881-888
13. Kjoller-Hansen L., Steffensen R., and Grande P. Extended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post REvascularization Study (APRES). Am Heart J 148 (2004) 475-480
14. Herlitz J. Secondary prevention after coronary artery bypass grafting-what do we know?. Scand Cardiovasc J 38 (2004) 69-74
15. Smith Jr. S.C., Blair S.N., Bonow R.O., et al. AHA/ACC scientific statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 104 (2001) 1577-1579
16. EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362 (2003) 782-788
17. Alpert J.S., Thygesen K., Antman E., et al. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
18. PEACE Trial Investigators. Angiotensin-converting enzyme inhibition in stable coronary artery disease. N Engl J Med 351 (2004) 2058-2068
19. Pitt B., O'Neill B., Feldman R., et al., QUIET Study Group. The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. Am J Cardiol 87 (2001) 1058-1063
20. Yusuf S., and Pogue J. ACE inhibition in stable coronary artery disease. N Engl J Med 352 (2005) 937-938
21. Pfeffer M.A., Domanski M.J., and Braunwald E. ACE inhibition in stable coronary artery disease. [Letter]. N Engl J Med 352 (2005) 937-939
22. Dagenais G.R., Pogue J., Fox K., et al. Angiotensin-converting enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. Lancet 368 (2006) 581-588
23. Warnica J.W., Gilst W.V., Baillot R., et al. Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting Enzyme (IMAGINE): a multicentre randomized trial-design and rationale. Can J Cardiol 18 (2002) 1191-1200